France · Pharmaceuticals
Pharmaceuticals
Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women's health; Orphan diseases. With more than 1,600 employees, Biocodex generated net revenues of above €500 million in 2022, including 1/3 in France and 2/3 internationally. The group is present in 115 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide.
1953
Founded
Pharmaceuticals
Industry
France
Location
3,112,884
Ranking
1,800 employees
Size

Get full access to view complete information
